{"pmid":32333127,"title":"COVID-19 challenging cell biology.","text":["COVID-19 challenging cell biology.","Protoplasma","Bullerdiek, Joern","32333127"],"journal":"Protoplasma","authors":["Bullerdiek, Joern"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333127","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s00709-020-01506-z","source":"PubMed","weight":0,"_version_":1665071049641820160,"score":8.518259,"similar":[{"pmid":32269085,"pmcid":"PMC7144260","title":"Pathogenesis of COVID-19 from a cell biology perspective.","text":["Pathogenesis of COVID-19 from a cell biology perspective.","Eur Respir J","Mason, Robert J","32269085"],"journal":"Eur Respir J","authors":["Mason, Robert J"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269085","week":"202015|Apr 06 - Apr 12","doi":"10.1183/13993003.00607-2020","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664637315647012865,"score":73.435814},{"pmid":32327746,"title":"Translating IL-6 biology into effective treatments.","text":["Translating IL-6 biology into effective treatments.","In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is important for antibody production by B cells. Since its discovery more than 40 years ago, the IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in health and dysregulation in many diseases. Targeting of the IL-6 pathway has led to innovative therapeutic approaches for various rheumatic diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, adult-onset Still's disease, giant cell arteritis and Takayasu arteritis, as well as other conditions such as Castleman disease and cytokine release syndrome. Targeting this pathway has also identified avenues for potential expansion into several other indications, such as uveitis, neuromyelitis optica and, most recently, COVID-19 pneumonia. To mark the tenth anniversary of anti-IL-6 receptor therapy worldwide, we discuss the history of research into IL-6 biology and the development of therapies that target IL-6 signalling, including the successes and challenges and with an emphasis on rheumatic diseases.","Nat Rev Rheumatol","Choy, Ernest H","De Benedetti, Fabrizio","Takeuchi, Tsutomu","Hashizume, Misato","John, Markus R","Kishimoto, Tadamitsu","32327746"],"abstract":["In 1973, IL-6 was identified as a soluble factor that is secreted by T cells and is important for antibody production by B cells. Since its discovery more than 40 years ago, the IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in health and dysregulation in many diseases. Targeting of the IL-6 pathway has led to innovative therapeutic approaches for various rheumatic diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, adult-onset Still's disease, giant cell arteritis and Takayasu arteritis, as well as other conditions such as Castleman disease and cytokine release syndrome. Targeting this pathway has also identified avenues for potential expansion into several other indications, such as uveitis, neuromyelitis optica and, most recently, COVID-19 pneumonia. To mark the tenth anniversary of anti-IL-6 receptor therapy worldwide, we discuss the history of research into IL-6 biology and the development of therapies that target IL-6 signalling, including the successes and challenges and with an emphasis on rheumatic diseases."],"journal":"Nat Rev Rheumatol","authors":["Choy, Ernest H","De Benedetti, Fabrizio","Takeuchi, Tsutomu","Hashizume, Misato","John, Markus R","Kishimoto, Tadamitsu"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327746","week":"202017|Apr 20 - Apr 26","doi":"10.1038/s41584-020-0419-z","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664996915014533120,"score":49.2785},{"pmid":32254054,"pmcid":"PMC7137107","title":"Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.","text":["Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.","Acta Crystallogr D Struct Biol","Baker, Edward N","32254054"],"journal":"Acta Crystallogr D Struct Biol","authors":["Baker, Edward N"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32254054","week":"202015|Apr 06 - Apr 12","doi":"10.1107/S2059798320004830","keywords":["covid-19","sars-cov-2","coronaviruses","editorial"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664640769860829184,"score":42.330593},{"pmid":32254048,"pmcid":"PMC7137381","title":"Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.","text":["Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.","Acta Crystallogr F Struct Biol Commun","Baker, Edward N","32254048"],"journal":"Acta Crystallogr F Struct Biol Commun","authors":["Baker, Edward N"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32254048","week":"202015|Apr 06 - Apr 12","doi":"10.1107/S2053230X20004847","keywords":["covid-19","sars-cov-2","coronaviruses","editorial"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664640769865023488,"score":42.330593},{"pmid":32161092,"title":"The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.","text":["The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.","The new decade of the 21(st) century (2020) started with the emergence of novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans and mechanisms associated with the pathogenicity of SARS-CoV-2 are not clear yet, however, its resemblance with SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infected people. In this Review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.","J Clin Microbiol","Khan, Suliman","Siddique, Rabeea","Shereen, Muhammad Adnan","Ali, Ashaq","Liu, Jianbo","Bai, Qian","Bashir, Nadia","Xue, Mengzhou","32161092"],"abstract":["The new decade of the 21(st) century (2020) started with the emergence of novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans and mechanisms associated with the pathogenicity of SARS-CoV-2 are not clear yet, however, its resemblance with SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infected people. In this Review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2."],"journal":"J Clin Microbiol","authors":["Khan, Suliman","Siddique, Rabeea","Shereen, Muhammad Adnan","Ali, Ashaq","Liu, Jianbo","Bai, Qian","Bashir, Nadia","Xue, Mengzhou"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32161092","week":"202011|Mar 09 - Mar 15","doi":"10.1128/JCM.00187-20","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874792878082,"score":41.998726}]}